Oktay Halit Aktepe

26PUBLICATIONS
38CO-AUTHORS
Liquid biopsiesTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 16, 2026
Anxiety, depression, and quality of life in metastatic cancer patients receiving immune checkpoint inhibitors: A 2-center cross-sectional study.

|May 27, 2026
Immune Phenotyping Using Neutrophil-to-Lymphocyte Ratio and Tumor-Infiltrating Lymphocytes Predicts Recurrence in Resected Melanoma.

|May 27, 2026
Prognostic Significance of Cdc42 Expression in Colorectal Cancer and Its Concordance Between Primary Tumors and Matched Metastases: A Retrospective Observational Study.

|May 27, 2026
Elevated B12/CRP Index as a Simple Prognostic Indicator in Patients with Metastatic Renal Cell Carcinoma Treated with First-Line Targeted Therapy.

|May 21, 2026
Multicenter Real-World Evaluation of Neoadjuvant Carboplatin in Triple-Negative Breast Cancer.

|Mar 14, 2026
Baseline Red Blood Cell Distribution Width as a Prognostic Marker in High-Risk Resected Cutaneous Melanoma.

Omer Ekin, Oktay Halit Aktepe

Pageof 5

Frequent Collaborators

6 joint publications

Denizcan Güven

4 joint publications

Taha Koray Şahin

4 joint publications

Gurkan Guner

3 joint publications

Hakan Taban